Luzzatto L, Apirion D, Schlessinger D
J Bacteriol. 1969 Jul;99(1):206-9. doi: 10.1128/jb.99.1.206-209.1969.
Inhibition of protein synthesis by streptomycin was tested in extracts from a strain of Escherichia coli sensitive to streptomycin. Three kinds of messenger ribonucleic acid (RNA) were employed: endogenous cellular RNA, extracted cellular RNA, and phage R17 RNA. Protein synthesis directed by extracted cellular RNA was inhibited three- to fourfold more than protein synthesis directed by endogenous RNA. With R17 RNA as messenger, nearly total inhibition of protein synthesis at initiation was again observed. The greater inhibition of function of extracted RNA, which must initiate new polypeptide chains in vitro, is in accord with the observation that in whole cells streptomycin blocks ribosomes at an early stage in protein synthesis. When streptomycin was added at successively later times during protein synthesis, the subsequent inhibition was progressively less. This was observed with either extracted cellular RNA or phage R17 RNA. A model is presented that can explain the less drastic inhibition by streptomycin of messenger RNA that is already functioning on ribosomes.
在对链霉素敏感的大肠杆菌菌株提取物中测试了链霉素对蛋白质合成的抑制作用。使用了三种信使核糖核酸(RNA):内源性细胞RNA、提取的细胞RNA和噬菌体R17 RNA。由提取的细胞RNA指导的蛋白质合成比由内源性RNA指导的蛋白质合成受到的抑制高三到四倍。以R17 RNA作为信使时,再次观察到在起始阶段蛋白质合成几乎完全受到抑制。对必须在体外起始新多肽链的提取RNA功能的更大抑制,与在完整细胞中链霉素在蛋白质合成早期阻断核糖体的观察结果一致。当在蛋白质合成过程中依次在较晚时间添加链霉素时,随后的抑制作用逐渐减弱。这在提取的细胞RNA或噬菌体R17 RNA中均有观察到。提出了一个模型,该模型可以解释链霉素对已经在核糖体上起作用的信使RNA的抑制作用不那么剧烈的现象。